Dopamine Transporter: Biochemistry, Pharmacology and Imaging
- 1 January 1990
- journal article
- research article
- Published by S. Karger AG in European Neurology
- Vol. 30 (1) , 15-20
- https://doi.org/10.1159/000117169
Abstract
In recent years, there has been substantial progress in studying the dopamine transporter, a unique component of the functioning dopaminergic nerve terminal. The transporter has been studied by direct binding techniques using a variety of ligands which function as inhibitors of transport. Analogues of these ligands have been used as photoaffinity labels to solubilize and further characterize the transporter. While a variety of drugs bind to the transporter, it is clear that the transporter may serve as an important drug receptor, particularly for the reinforcing properties of some psychostimulants such as cocaine. An extension of the in vitro ligand-binding studies reveals that it is possible to preferentially label the transporter in vivo. The success of in vivo labeling has lead to successful positron emission tomographic scanning studies of the transporter. These studies in turn have revealed the usefulness of imaging the transporter, a measure of the presence of dopaminergic nerve terminals, as a potential diagnostic tool in Parkinson’s disease.This publication has 18 references indexed in Scilit:
- Biochemical and Pharmacological Characterization of [3H]GBR 12935 Binding In Vitro to Rat Striatal Membranes: Labeling of the Dopamine Uptake ComplexJournal of Neurochemistry, 1987
- Characterization of Sodium‐Dependent [3H]GBR‐12935 Binding in Brain: A Radioligand for Selective Labelling of the Dopamine Transport ComplexJournal of Neurochemistry, 1986
- GBR 12783, a potent and selective inhibitor of dopamine uptake: Biochemical studies in vivo and ex vivoEuropean Journal of Pharmacology, 1986
- Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons diseaseNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1985
- Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranesBiochemical Pharmacology, 1985
- Quantitative autoradiography of 3H-nomifensine binding sites in rat brainLife Sciences, 1985
- The effects of surgical and chemical lesions on striatal binding: Correlation with [3H]dopamine uptakeEuropean Journal of Pharmacology, 1985
- [H-3] MAZINDOL BINDING ASSOCIATED WITH NEURONAL DOPAMINE AND NOREPINEPHRINE UPTAKE SITES1984
- Sodium‐Sensitive Cocaine Binding to Rat Striatal Membrane: Possible Relationship to Dopamine Uptake SitesJournal of Neurochemistry, 1983
- Neurotransmitter uptake: A tool in identifying neurotransmitter-specific pathwaysLife Sciences, 1973